Financhill
Sell
15

AKYA Quote, Financials, Valuation and Earnings

Last price:
$2.36
Seasonality move :
-6.47%
Day range:
$2.34 - $2.60
52-week range:
$1.88 - $6.31
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.41x
P/B ratio:
9.02x
Volume:
365.6K
Avg. volume:
354.6K
1-year change:
-47.35%
Market cap:
$122.9M
Revenue:
$96.6M
EPS (TTM):
-$1.18
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $42.2M $42.4M $54.9M $74.9M $96.6M
Revenue Growth (YoY) -- 0.49% 29.39% 36.31% 29.09%
 
Cost of Revenues $17.6M $16.5M $20.7M $31.5M $40.3M
Gross Profit $24.7M $25.9M $34.2M $43.4M $56.3M
Gross Profit Margin 58.39% 61.04% 62.31% 57.96% 58.27%
 
R&D Expenses $8.8M $9.6M $15.7M $23.2M $21.9M
Selling, General & Admin $26.4M $24M $51M $79.7M $82.4M
Other Inc / (Exp) $828K -$2.4M -$2.8M -$533K -$2M
Operating Expenses $38.2M $37.4M $71.4M $109.6M $112.3M
Operating Income -$13.5M -$11.5M -$37.2M -$66.2M -$56M
 
Net Interest Expenses $1.9M $2.7M $3M $3.8M $5.3M
EBT. Incl. Unusual Items -$14.6M -$16.7M -$43.1M -$70.5M -$63.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $194K $42K -$140K $123K $40K
Net Income to Company -$14.8M -$16.7M -$42.9M -$70.6M -$63.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$14.8M -$16.7M -$42.9M -$70.6M -$63.3M
 
Basic EPS (Cont. Ops) -$0.63 -$0.75 -$1.65 -$1.87 -$1.43
Diluted EPS (Cont. Ops) -$0.63 -$0.75 -$1.65 -$1.87 -$1.43
Weighted Average Basic Share $28.9M $28.9M $26.9M $37.7M $44.4M
Weighted Average Diluted Share $28.9M $28.9M $26.9M $37.7M $44.4M
 
EBITDA -$9.6M -$10.1M -$35.2M -$58.8M -$45.6M
EBIT -$12.7M -$13.9M -$40M -$66M -$54.5M
 
Revenue (Reported) $42.2M $42.4M $54.9M $74.9M $96.6M
Operating Income (Reported) -$13.5M -$11.5M -$37.2M -$66.2M -$56M
Operating Income (Adjusted) -$12.7M -$13.9M -$40M -$66M -$54.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $10M $13.5M $18.9M $25.2M $18.8M
Revenue Growth (YoY) -- 35.38% 39.89% 33.75% -25.39%
 
Cost of Revenues $3.9M $5M $7.9M $9.9M $7.1M
Gross Profit $6M $8.5M $10.9M $15.3M $11.7M
Gross Profit Margin 60.62% 62.73% 57.86% 60.58% 62.32%
 
R&D Expenses $2.3M $4M $5.5M $6.3M $4.5M
Selling, General & Admin $5.7M $13.7M $19.9M $20.3M $14.7M
Other Inc / (Exp) -$682K -$350K -$582K -$447K -$963K
Operating Expenses $9M $19M $27.2M $26.6M $19.1M
Operating Income -$2.9M -$10.5M -$16.3M -$11.3M -$7.4M
 
Net Interest Expenses $683K $763K $973K $1.2M $2.1M
EBT. Incl. Unusual Items -$4.3M -$11.6M -$17.9M -$12.9M -$10.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$9K -$11K $21K $15K $44K
Net Income to Company -$4.3M -$11.6M -$17.9M -$12.9M -$10.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$4.3M -$11.6M -$17.9M -$12.9M -$10.5M
 
Basic EPS (Cont. Ops) -$0.20 -$0.31 -$0.47 -$0.26 -$0.21
Diluted EPS (Cont. Ops) -$0.20 -$0.31 -$0.47 -$0.26 -$0.21
Weighted Average Basic Share $28.9M $37.2M $37.9M $49M $49.5M
Weighted Average Diluted Share $28.9M $37.2M $37.9M $49M $49.5M
 
EBITDA -$2.6M -$9.6M -$14.8M -$8.1M -$6M
EBIT -$3.6M -$10.9M -$16.7M -$10.7M -$7.9M
 
Revenue (Reported) $10M $13.5M $18.9M $25.2M $18.8M
Operating Income (Reported) -$2.9M -$10.5M -$16.3M -$11.3M -$7.4M
Operating Income (Adjusted) -$3.6M -$10.9M -$16.7M -$10.7M -$7.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- $51.7M $69.8M $91.4M $86.8M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- $19.8M $28.2M $39.6M $36.7M
Gross Profit -- $31.9M $41.6M $51.7M $50.1M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- $12.7M $22.3M $26M $17.6M
Selling, General & Admin -- $38.8M $77.8M $88.2M $68.7M
Other Inc / (Exp) $63K -$4.1M -$1.3M -$1.9M -$6.5M
Operating Expenses -- $55.8M $106.4M $116M $94.4M
Operating Income -- -$23.9M -$64.9M -$64.3M -$44.3M
 
Net Interest Expenses $2M $3M $3.2M $5.2M $7.1M
EBT. Incl. Unusual Items -- -$31M -$69.4M -$71.4M -$57.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -$49K $32K $36K $132K
Net Income to Company -- -$31M -$69.4M -$71.4M -$58M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -$31M -$69.4M -$71.4M -$58M
 
Basic EPS (Cont. Ops) -- -$1.02 -$1.85 -$1.76 -$1.18
Diluted EPS (Cont. Ops) -- -$1.02 -$1.85 -$1.76 -$1.18
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -$23.5M -$59.2M -$54.4M -$39.8M
EBIT -- -$28M -$65.9M -$63M -$47.7M
 
Revenue (Reported) -- $51.7M $69.8M $91.4M $86.8M
Operating Income (Reported) -- -$23.9M -$64.9M -$64.3M -$44.3M
Operating Income (Adjusted) -- -$28M -$65.9M -$63M -$47.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $29.5M $38.8M $53.6M $70.1M $60.3M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $11.5M $14.8M $22.3M $30.5M $26.8M
Gross Profit $18M $24M $31.3M $39.7M $33.5M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $7.1M $10.1M $16.8M $19.6M $15.3M
Selling, General & Admin $17.2M $32M $58.7M $67.3M $53.6M
Other Inc / (Exp) $63K -$1.5M -$8K -$1.4M -$5.8M
Operating Expenses $27M $45.5M $80.5M $86.9M $68.9M
Operating Income -$9M -$21.5M -$49.1M -$47.2M -$35.5M
 
Net Interest Expenses $2M $2.3M $2.5M $3.9M $5.7M
EBT. Incl. Unusual Items -$10.9M -$25.3M -$51.6M -$52.5M -$47M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $68K -$23K $149K $62K $154K
Net Income to Company -$11M -$25.3M -$51.8M -$52.5M -$47.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$11M -$25.3M -$51.8M -$52.5M -$47.2M
 
Basic EPS (Cont. Ops) -$0.48 -$0.78 -$1.38 -$1.26 -$0.96
Diluted EPS (Cont. Ops) -$0.48 -$0.78 -$1.38 -$1.26 -$0.96
Weighted Average Basic Share $86.7M $102.8M $113M $127.9M $148.1M
Weighted Average Diluted Share $86.7M $102.8M $113M $127.9M $148.1M
 
EBITDA -$6.2M -$19.6M -$43.7M -$39.2M -$33.4M
EBIT -$9M -$23M -$48.9M -$46M -$39.2M
 
Revenue (Reported) $29.5M $38.8M $53.6M $70.1M $60.3M
Operating Income (Reported) -$9M -$21.5M -$49.1M -$47.2M -$35.5M
Operating Income (Adjusted) -$9M -$23M -$48.9M -$46M -$39.2M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $11.6M $17M $113.1M $74.2M $83.1M
Short Term Investments $10M -- -- $7M --
Accounts Receivable, Net $13.2M $6.5M $9.4M $9.7M $17M
Inventory $4.1M $4.3M $9M $14.5M $17.9M
Prepaid Expenses -- -- -- -- --
Other Current Assets $2M $957K $9.3M $6.8M $3.8M
Total Current Assets $40.9M $28.7M $140.8M $112.2M $121.8M
 
Property Plant And Equipment $5M $5.5M $7.5M $22.4M $20.7M
Long-Term Investments -- -- -- -- --
Goodwill $18.3M $18.3M $18.3M $18.3M $18.3M
Other Intangibles $24.1M $22.7M $21.2M $20M $17.4M
Other Long-Term Assets $1.2M $2.5M $3.2M $3.1M $2.2M
Total Assets $89.4M $77.7M $190.9M $176M $180.4M
 
Accounts Payable $8.1M $5.1M $9.4M $10.6M $11.8M
Accrued Expenses $6M $5.4M $12.3M $11.2M $10.4M
Current Portion Of Long-Term Debt -- $1M -- -- --
Current Portion Of Capital Lease Obligations $80K $197K $272K $3.6M $3.4M
Other Current Liabilities $2.5M $1.6M $1.2M $1.7M $1.9M
Total Current Liabilities $21.2M $17.2M $27.7M $37.1M $35.3M
 
Long-Term Debt $24.5M $33.5M $32.5M $63.3M $75.3M
Capital Leases -- -- -- -- --
Total Liabilities $119.6M $128.7M $69.6M $117.5M $126.6M
 
Common Stock $1.3M $1.3M $2K $2K $2K
Other Common Equity Adj -- -- -- -$6K --
Common Equity -$31.4M -$52.3M $121.4M $58.6M $53.8M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$30.2M -$51M $121.4M $58.6M $53.8M
 
Total Liabilities and Equity $89.4M $77.7M $190.9M $176M $180.4M
Cash and Short Terms $21.7M $17M $113.1M $81.2M $83.1M
Total Debt $24.5M $34.5M $32.5M $63.3M $75.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- $120.2M $51.8M $78.6M $12.6M
Short Term Investments -- -- $29.9M -- $23.3M
Accounts Receivable, Net -- $9.6M $8.7M $16.1M $12.8M
Inventory -- $6.1M $13.1M $18.8M $25.2M
Prepaid Expenses -- -- -- -- --
Other Current Assets -- $9.8M $8.3M $3.5M $3M
Total Current Assets -- $145.7M $111.7M $116.9M $76.9M
 
Property Plant And Equipment -- $6.5M $23.3M $21.6M $14M
Long-Term Investments -- -- -- -- $3.4M
Goodwill -- $18.3M $18.3M $18.3M $18.3M
Other Intangibles -- $21.4M $20.4M $18.1M $15.3M
Other Long-Term Assets -- $3.6M $2.7M $2.3M $2.2M
Total Assets -- $195.4M $176.5M $177.2M $130M
 
Accounts Payable -- $4.1M $8.2M $11.9M $8.8M
Accrued Expenses -- $7.4M $12.7M $9.8M $6.8M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- $279K $3.6M $3.6M $3.7M
Other Current Liabilities -- $1.2M $1.3M $1.8M $1.4M
Total Current Liabilities -- $17.3M $31.7M $35.5M $28M
 
Long-Term Debt -- $32.4M $52.7M $63.8M $75.9M
Capital Leases -- -- -- -- --
Total Liabilities -- $58M $101.4M $115.3M $116.3M
 
Common Stock -- $2K $2K $2K $2K
Other Common Equity Adj -- -- -$66K -- $8K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- $137.4M $75.1M $62M $13.6M
 
Total Liabilities and Equity -- $195.4M $176.5M $177.2M $130M
Cash and Short Terms -- $120.2M $81.7M $78.6M $35.9M
Total Debt -- $32.4M $52.7M $63.8M $75.9M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$14.8M -$16.7M -$42.9M -$70.6M -$63.3M
Depreciation & Amoritzation $3.1M $3.8M $4.8M $7.1M $8.9M
Stock-Based Compensation $153K $477K $4M $7.4M $10.4M
Change in Accounts Receivable -$3.4M $6.7M -$3M -$285K -$7.3M
Change in Inventories -$4M -$684K -$4.6M -$5.4M -$6.3M
Cash From Operations -$13.8M -$6.8M -$36.1M -$53.5M -$50.9M
 
Capital Expenditures $2.9M $3.3M $5.1M $7.4M $3.7M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$12.9M $6.7M -$5.1M -$14.1M $3.3M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $30M $35M -- $31.3M $11.3M
Long-Term Debt Repaid -$25M -$25.2M -$322K -$621K -$676K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$1.2M -$4.4M -$1.6M -$2.4M -$2M
Cash From Financing $28.6M $5.5M $137M $28.7M $56.8M
 
Beginning Cash (CF) $10.2M $12.1M $17.5M $113.4M $74.5M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.9M $5.4M $95.9M -$38.8M $9.3M
Ending Cash (CF) $12.1M $17.5M $113.4M $74.5M $83.8M
 
Levered Free Cash Flow -$16.6M -$10.1M -$41.2M -$60.9M -$54.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$4.3M -$11.6M -$17.9M -$12.9M -$10.5M
Depreciation & Amoritzation $971K $1.2M $1.9M $2.6M $1.8M
Stock-Based Compensation $60K $1.2M $2M $2.9M $1.9M
Change in Accounts Receivable -$1.5M -$1.4M $1.8M -$3.2M $3.8M
Change in Inventories -$387K $267K $155K -$3M -$782K
Cash From Operations -$1.7M -$13.4M -$12.2M -$13.8M -$9.3M
 
Capital Expenditures $862K $1.9M $3.8M $832K $434K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$902K -$1.9M $7.3M -$832K $13M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $10M -- --
Long-Term Debt Repaid -$48K -$74K -$142K -$175K -$166K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -$38K -- --
Cash From Financing $40K -$44K $9.9M -$141K -$150K
 
Beginning Cash (CF) $6.9M $135.8M $47.2M $93.7M $9.6M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$2.6M -$15.3M $5M -$14.7M $3.6M
Ending Cash (CF) $4.3M $120.5M $52.1M $78.9M $13.2M
 
Levered Free Cash Flow -$2.6M -$15.3M -$16M -$14.6M -$9.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -$31M -$69.4M -$71.4M -$58M
Depreciation & Amoritzation -- $4.4M $6.6M $8.7M $7.9M
Stock-Based Compensation $423K $2.7M $6.7M $10M $9.7M
Change in Accounts Receivable -- -$4.1M $925K -$7.4M $2.4M
Change in Inventories -- -$2.7M -$6.3M -$8.4M -$9.7M
Cash From Operations -- -$32.4M -$49.3M -$55.3M -$46.7M
 
Capital Expenditures $2.8M $4.2M $7.9M $3.9M $2M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- $5.9M -$37.6M $26.1M -$27.3M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -$25.3M -$530K -$659K -$700K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$3M -$2.3M
Cash From Financing -- $142.6M $18.6M $56M $8.4M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- $116.1M -$68.3M $26.8M -$65.7M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -$36.6M -$57.2M -$59.3M -$48.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$11M -$25.3M -$51.8M -$52.5M -$47.2M
Depreciation & Amoritzation $2.8M $3.4M $5.2M $6.8M $5.8M
Stock-Based Compensation $423K $2.6M $5.3M $7.9M $7.2M
Change in Accounts Receivable $7.6M -$3.1M $764K -$6.4M $3.3M
Change in Inventories -$276K -$2.3M -$4M -$7M -$10.4M
Cash From Operations -$4.7M -$30.2M -$43.5M -$45.3M -$41.1M
 
Capital Expenditures $2.8M $3.7M $6.5M $3.1M $1.4M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$2.9M -$3.7M -$36.2M $3.9M -$26.7M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2.5M -- $20M -- --
Long-Term Debt Repaid -$142K -$250K -$458K -$496K -$520K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$2.6M -$1.6M -$1.3M -$2M -$2.3M
Cash From Financing -$201K $136.9M $18.5M $45.8M -$2.7M
 
Beginning Cash (CF) $26.1M $165.5M $254.8M $228.7M $107.2M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$7.8M $102.9M -$61.2M $4.4M -$70.6M
Ending Cash (CF) $18.3M $268.4M $193.6M $233.1M $36.6M
 
Levered Free Cash Flow -$7.5M -$33.9M -$50M -$48.4M -$42.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 6.55% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 7.5% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.29% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock